Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.61M Buy
27,316
+176
+0.6% +$62.7K 5.17% 5
2025
Q4
$8.88M Buy
27,140
+14,302
+111% +$4.54M 4.71% 5
2025
Q3
$3.62M Buy
12,838
+5,658
+79% +$1.64M 2.07% 19
2025
Q2
$2M Buy
7,180
+298
+4% +$84.4K 1.25% 24
2025
Q1
$2.14M Buy
6,882
+13
+0.2% +$3.84K 1.46% 21
2024
Q4
$1.79M Buy
6,869
+389
+6% +$115K 1.2% 23
2024
Q3
$2.09M Buy
6,480
+3
+0% +$981 1.44% 22
2024
Q2
$2.02M Buy
6,477
+32
+0.5% +$9.4K 1.57% 22
2024
Q1
$1.83M Buy
6,445
+4
+0.1% +$1.17K 1.54% 21
2023
Q4
$1.86M Buy
6,441
+8
+0.1% +$2.18K 1.72% 18
2023
Q3
$1.73M Sell
6,433
-51
-0.8% -$12.7K 1.77% 18
2023
Q2
$1.44M Buy
6,484
+1,176
+22% +$273K 1.38% 20
2023
Q1
$1.39M Hold
5,308
1.39% 20
2022
Q4
$1.39M Sell
5,308
-57
-1% -$15.3K 1.39% 20
2022
Q3
$1.21M Hold
5,365
1.3% 21
2022
Q2
$1.3M Hold
5,365
1.36% 20
2022
Q1
$1.3M Buy
5,365
+50
+0.9% +$11.5K 1.14% 21
2021
Q4
$1.2M Buy
+5,315
New +$1.12M 1.08% 20

Other funds holding AMGN

Hofer & Associates's AMGN Position: Q1 2026 in Review

Hofer & Associates increased its Amgen (AMGN) stake by 0.65% in Q1 2026, buying an estimated $62.7K and bringing the position to 27,316 shares worth $9.61M. The position accounts for 5.17% of the portfolio, ranked #5.

Hofer & Associates first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Hofer & Associates held 27,316 shares of Amgen worth $9.61M as of Q1 2026.
  • Hofer & Associates bought 176 Amgen shares in Q1 2026, an estimated $62.7K.
  • Amgen made up 5.17% of Hofer & Associates's portfolio in Q1 2026, its #5 holding.
  • Hofer & Associates first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Hofer & Associates's 13F filing for Q1 2026, filed 22 Apr 2026.